Wednesday, April 18, 2018

Could stem cell therapy be an effective treatment for Friedreich’s ataxia?

University of Bristol, Press release issued: 17 April 2018

Researchers at the University of Bristol are looking for people with an inherited neurological condition called Friedreich's ataxia (FA) to take part in a study into whether a stem cell therapy could be a treatment for FA.
The small, pilot study aims to recruit seven people to find out if the bone marrow stem cell mobilising drug, granulocyte-colony stimulating factor (GCSF), could improve blood markers and potentially treat the condition.